Conference Call Begins at 4:30 p.m. Eastern Time TodayEMERYVILLE, Calif.--(BUSINESS WIRE)--$OABI #OABI--OmniAb, Inc. (NASDAQ: ...
U.S. FDA places FREEDOM2 trial on partial clinical hold related to preclinical pharmacology and toxicology -- Received regulatory clearance to initiate FREEDOM2 in South Korea, Australia, and New ...
Peer reviewed - observational study - humansThe Covid pandemic disrupted children’s ability to self-regulate - according to ...
Pete Pharma, a pharmaceutical innovation and IP development company focused on modernizing dosage forms through advanced 3D ...
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that the Company, both in the USA and in Israel, is not ...
France has launched a fast track clinical trial approval pathway that could reduce authorisation times to as little as 14 ...
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and ...
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and ...
OverviewThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value of USD ...
Overview of Medical Radiation Shielding MarketThe Medical Radiation Shielding Market plays a critical role in ensuring safety ...
Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing ...
Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide developmentBOULDER, Colo.--(BUSINESS WIRE)--BioMed Realty, the largest private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results